IGF1 and breast carcinoma: Circulating estrogens, androgens, and insulin-like growth factor 1 (IGF-1) have been associated with an increased risk of breast cancer in women, whereas sex hormone-binding globulin (SHBG) is inversely associated with the risk (7–10).